Replies to post #122325 on Biotech Values

[DewDiligence]

CHMP approves Tradjenta in combination with insulin:

http://finance.yahoo.com/news/chmp-recommends-indication-trajenta-linagliptin-122000194.html

Tradjenta, from a JV of LLY and B-I, was approved in the EU as a monotherapy in 2011 (#msg-64617999).

In the US, Tradjenta is approved both as monotherapy and in combination with metformin (under the brand name, Jentadueto).